[1]
Ravasio, R., Girolomoni, G. and Gorla, R. 2018. Budget impact analysis of the etanercept biosimilar: the Italian scenario. Global and Regional Health Technology Assessment. 5, 1 (Apr. 2018). DOI:https://doi.org/10.33393/grhta.2018.444.